Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows 0 21.12.2024 00:30 Fortune.com About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo. Read More Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
